Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.10 0.97% 10.425 575,130 16:35:29
Bid Price Offer Price High Price Low Price Open Price
10.15 10.70 11.00 10.50 10.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 6.24 -4.74 -1.48 32
Last Trade Time Trade Type Trade Size Trade Price Currency
16:27:24 O 12,750 10.26 GBX

Plant Health Care (PHC) Latest News (1)

More Plant Health Care News
Plant Health Care Investors    Plant Health Care Takeover Rumours

Plant Health Care (PHC) Discussions and Chat

Plant Health Care (PHC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2022-08-12 15:27:2410.2612,7501,308.15O
2022-08-12 14:52:2610.528,362880.02O
View all Plant Health Care trades in real-time

Plant Health Care (PHC) Top Chat Posts

DateSubject
13/8/2022
09:20
Plant Health Care Daily Update: Plant Health Care Plc is listed in the Chemicals sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 10.33p.
Plant Health Care Plc has a 4 week average price of 8.95p and a 12 week average price of 8.80p.
The 1 year high share price is 14.40p while the 1 year low share price is currently 8.80p.
There are currently 302,387,482 shares in issue and the average daily traded volume is 115,686 shares. The market capitalisation of Plant Health Care Plc is £31,523,895.
12/8/2022
08:43
my retirement fund: Against a back drop of these high fertilizer prices, climate stressed agriculture and increasingly clear food insecurity, PHC should do well.
12/8/2022
08:37
cerrito: I have no issue with these grants. I see that the share count could go up 1.8pc when the share price hits 17p and I am OK with that.
08/8/2022
08:33
cerrito: It has come up in the IMC sessions that trading of PHC shares on the US OTC market has been disappointing. I have done some digging this morning on the different OTC markets and have seen that the market PHC is on is the lower quality one of the OTCQB rather than the higher quality OTCQX.
22/7/2022
09:38
blackswann: Hi, there were x2 lots of options granted at a 1p strike rateThe first batch of which there are just over 3m left.70% of these can be take if the share price AVERAGE over a 30 day period is 15p. The remaining 30% can be taken if the average share price over a 30 say period is 27p.The second batch of which there are just under 5m left.70% of these can be taken if the share price average over 30 days is 22p with the remaining available if share price average over 30 days hits 33p.Both batches expire in 2027.Options is one thing but proper skin in the game is the other. I like these a lot but the lack of director own money in is a bit of a ,let's say Amber flag. Not a red flag.A decent buy from a director at this level would complete the investment case for me and I would go all in. At present I think I'll scale in slowly just incase
22/7/2022
08:35
pretax2: Blackswann There is an interview from earlier this year where CR says that Ospraie we’re approach by a fund and asked if they would sell some of their stock to them. As for JT, I’ve also puzzled over why he doesn’t have more of a stake. The directors have performance related options with a strike of 1p. CR told me they vest much higher, but didn’t say how high. So if I’m JT I might ask ‘do I want 2m shares at 10p right now or 2m at 1p when the share-price is significantly higher?’ If I’m confident that the price is going up, I’d hang on for the options. I’ve never been seduced into thinking that the current share-price reflects the value or potential of PHC, but sometimes you have to wait for Mr Market to come to his senses. Sorry for long winded reply.
22/7/2022
06:58
pretax2: A 60% increase in H1 sales is a better indicator of company health than institutional and director dealing. There are many indirect factors influencing institutional and director dealing. I’ve known institutions offloading just before share prices go on huge bull runs. Sometimes to create liquidity in the stock. Look at i3e. There were 5x institutional sells just before the had a 300% rise.
21/7/2022
19:06
cerrito: I am encouraged that Lombard Odier can reduce their holding by 5% of the shares outstanding and the share price more or less takes it in its stride.
13/7/2022
23:22
cerrito: Thanks for highlighting this interview that passed me by. Good to hear him be so optimistic about no need for a further fund raising. The mind boggles as to the number of shares they would have to issue at current exchange rates and of course the share price.
19/1/2022
17:51
cerrito: Arden’s note on Research Tree a good summary pf the WE IMC meeting. It was good to hear that 279 will have a shelf life of 5 years; interested in the WE comment that these days a new product launch needs greater investment in time and effort than before and also that if a new product has not caught on after three years it never will. Good that Arden’s forecast has $4m of cash at the end of 22 with no equity raises forecast for 22. The PHC share price is suffering the same fate as my pre profit clean tech stocks such as CWR and ITM.
27/5/2020
09:29
colin12345678: Highlights: US Corn - PHC 279 increased corn yields by 9-15% when applied as a foliar spray, creating potential grower value of $54 - $82 per acre at current average prices. - PHC279 significantly improved the control of two key corn diseases by as much as 50%, even under heavy disease pressure. Spring wheat - PHC279 increased yield by as much as 17% when added to the standard disease control program, which is worth $86 per acre at current prices. Lettuce - PHC279 increased yield by as much as 22% compared to fungicides alone. - PHC279 also improved disease control as much as 31% following foliar application. In the US, 91m acres of corn were planted in 2019. Severe southern rust disease can routinely reduce corn yields as much as 25 bushels per acre. At current prices, this would equate to lost revenue for the farmer of $79 per acre. In historical epidemics of southern corn leaf blight, yields were reduced by 20 to 25 percent nationwide, resulting in an estimated $1 billion loss in harvest. In the Company's trials, when PHC279 was applied together with a leading chemical fungicide, it significantly improved control of both diseases compared to the fungicide treatment alone, and yields were increased by as much as 26 bushels per acre depending on application timing. Even a more modest benefit of 5-10 bushels per acre is likely to provide an attractive return on investment in the potential range of 5:1 to 8:1 for farmers who apply PHC279 to their fields. In the UK, when PHC279 was applied to spring wheat seeds prior to planting, followed by adding it to the standard spray fungicide program, yield was increased by as much as 17% in fields with Septoria tritici blotch, the major disease of wheat in the UK. At current prices, this yield benefit would be worth $86 per acre to the farmer. Lettuce drop disease is a major pathogen affecting US lettuce cultivation. In a series of US field trials inoculated with Sclerotinia, the causative agent of lettuce drop disease, PHC279 treated plants yielded as much as 22% more than plants treated only with the standard chemical fungicide program. With an acre of lettuce worth more than $10,000 in the US in 2018, even a modest increase in lettuce yield will likely justify the cost of applying PHC279. Plant Health Care's PREtec peptides stimulate the plant to defend itself. Derived from natural proteins, this is a novel, environmentally friendly approach to protecting crops and increasing yields, compatible with mainstream agricultural practice. PHC279 may allow farmers to reduce applications of toxic fungicides or to achieve better control of disease. Gary L. Cloud, Ph.D., a research agronomist and owner of GLC Consulting, Inc. participated in the testing of PHC279 in corn this season, and offered the following, "There was heavy disease pressure and PHC279 provided visible improvement in disease control and higher yield compared to the standard fungicide when applied early in the growing season. That is somewhat amazing due to the time that elapsed between application and harvest. I believe PHC279 will be a valuable tool for corn growers struggling to control disease in their fields." Chris Richards, CEO of Plant Health Care, said "We are extremely encouraged with the performance of PHC279 in multiple key crops. Building on our recent success with PHC279 for the control of Asian soybean rust in Brazil, it is clear PHC279 will have important benefits for farmers in many crops. The registration of our first PREtec peptide is progressing in the US and Brazil and the scale-up of manufacturing has started. We are excited about the potential for products based on our PREtec peptides, which are targeting markets with an initial opportunity of $5 billion. We aim to launch the first peptides as soon as regulatory permits have been obtained, to offer these valuable new tools to growers in the US and other countries."
Plant Health Care share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
PHC
Plant Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220813 15:00:07